OPENCELL TECHNOLOGIES, INC.

OpenCell Technologies is a biotechnology company developing a cutting-edge, continuous, scalable, non-viral, cell-agnostic soft-poration transfection technology for intracellular delivery. The company's proprietary POROS platform uses acoustic force to push cells through an array of nozzles one cell at a time, creating shear force to porate cells and enabling efficient continuous delivery of large cargos — including DNA, RNA, and proteins — into challenging cell types. The technology expands the frontiers of cell engineering in biopharma, and is particularly relevant for CAR-T and other cell and gene therapy applications.